Abstract-Development of CAD systems for detection of prostate cancer has been a recent topic of research and remains a challenging task. In this paper, we propose a novel method of prostate cancer detection within the peripheral zone. The key idea is to assume that every grey level could be associated with malignant or normal tissues by using a weighted probability. Based on the weighting, we use specific metrics to determine abnormality. We show experimental results to illustrate the performance of this method in comparison to some previous studies. Initial results show that our method achieved 81% correct classification result and 9% and 10% false positive and false negative results, respectively (sensitivity/specificity: 0.85/0.72).
I. INTRODUCTION
With an estimate of 1.7 million cases globally by 2030 [1] , prostate cancer is one of the most common cancers affecting men, and is a leading cause of mortality in males [2] . In 2013, there were approximately 280,000 and 40,000 cases in the United State and United Kingdom, respectively [1] . Clinical diagnostic tools such as prostate-specific antigen (PSA) level, digital rectal examination (DRE), transrectual ultrasound (TRUS) and biopsy tests are used globally despite their inconsistent results (0.51-0.89 and 0.67-0.87 sensitivity and specificity, respectively) [3] . Some of these methods are invasive and patients can suffer stress from false-positive test results, subsequent evaluation, therapy, and "overtreatment" [2] .
Prostate magnetic resonance imaging (MRI) has the potential to improve the accuracy of clinical diagnostic tests [4] . Therefore the main goal of our research is to develop computer aided diagnosis (CAD) tools towards the detection of prostate abnormalities. Since 80-85% of the cancers arise within the peripheral zone [5] , the proposed method only considered abnormalities that occur within this region. There have been several studies which used only the peripheral zone of the prostate [6] [7] [8] and allows us to compare our quantitative results to these previous studies. Fig. 1 shows an example of prostate MRI image with its ground truth delineated by an expert radiologist and Fig. 2 shows a schematic overview of a prostate containing a tumor. The proposed method compares grey level histograms from each slice with models (e.g. normal and malignant histograms models) which were constructed based on training data the distribution of grey level. Subsequently, we use specific metrics to determine abnormality. There are several methods in the literature which have used histogram analysis techniques [9] [10] [11] [12] . A method proposed in [9] characterised each suspicious region of interest by performing histogram analysis on multiparametric MR images. On the other hand, [10] used colour channel histograms to capture the pattern of malignancy tissues in Gleason graded images. Moreover, [11] reports that features based histograms can achieve high sensitivity and specificity which is similar to some other features such as Gray Level Co-occurrence matrix (GLCM) and Grey Level Run-Length matrix (GLRLM). Finally, [12] used T2-weighted signal intensity histogram skewness as one of their features in differentiating between malignant and normal tissues. In terms of using grey level properties in detecting abnormalities, several studies have been done in medical image analysis application. The authors in [13] proposed a method for recognition of lung abnormalities based on four different templates describing typical geometry and grey level distribution of lung modules [13] . On the other hand, Yu [14] proposed a method which is relying on spatial grey level dependence for detecting and locating brain abnormality. Finally, the authors in [15] proposed a method using the distribution of grey level variations for abnormality detection in mammography.
In this paper we propose a new method for detecting prostate cancer within the peripheral zone using the distribution of grey levels. In comparison to the existing methods (detecting prostate cancer in medical images) in the literature, our method is different in the sense that we do not rely on texture features such as blobs and statistical features. The methods in [16] , [17] and [18] used texture features to classify malignant and normal tissue. Secondly, our method uses a single modality (T2-Weighted MRI) unlike the method in [19] , which used multimodality, i.e. diffusion MRI and MR Spectroscopy. Similarly, the method proposed in [9] used multiparametric MR, i.e. T1-and T2-weighted imaging. Finally, the proposed method is purely based on the grey levels information whereas the method in [9] used additional clinical diagnostic information such as biopsy tests in deciding whether cancer is truly present or not.
II. MODELLING THE PERIPHERAL ZONE
Since the proposed method only considers malignant tissues/regions within the PZ, it is important to define the PZ region. We use a simple method proposed in [20, 21] which uses a quadratic equation to define the boundary of PZ based on three vertex coordinates , and (which can be found based on the prostate's boundary). Fig. 3 shows an example how the PZ region is defined. The coordinates of , and can be determined based on the Cp (central coordinate), minimum and maximum x and y coordinates (x min , y min, x max and y max ) . A detailed description of the method can be found in [20, 21] . III. METHODOLOGY Fig. 4 shows the overview of the proposed algorithm. In summary, the methodology relies on the distribution of grey level within the histograms which were constructed based on the grey level occurrence within 44 malignant and normal regions. The histogram models represent the weighting values for every grey level. Based on the constructed histograms (88 slices) for each new slice, the histogram will be compared with the histogram models constructed in the early phase (yellow region in Fig. 4 ). 
A. Construction of Histograms
For every slice, the proposed method constructs the first histogram ( ) by taking every pixel intensity within the malignant region (note that all malignant regions were delineated by an expert radiologist) and each pixel is classified according to its intensity into an appropriate grey level. The second histogram ( ) is constructed using the same process with but taking normal regions instead. Normal regions are taken from the whole PZ region (with condition there is no tumors found within the PZ) as shown in Fig. 3 indigo region. This means and contain the distribution of malignant and normal grey level, respectively. Since every image size is 16 bits, there is a total of 65, 536 grey. There were 44 malignant and normal regions (in total 88 regions) taken from 44 slices (in total 88 slices all from 20 patients) to construct and . Mathematically, this process can be presented in (1), (2), (3) and (4).
where , , and represent the region (or grey level), every grey level, malignant and normal region, respectively. This means, there are 44 histograms in total from 44 malignant slices (another 44 histograms from normal slices). Finally, we combine all histograms using (3) and (4) to produce the resulting models. Fig. 5 illustrates an example of this process. 5 shows an example of the construction of based the n slices (in our case 44 slices). Note that the pixel intensities are only taken within the malignant region which is within the red boundary in Fig. 5 . The process is similar when constructing but taking the PZ region as defined in Fig. 3 . To this point we have constructed two histogram models which are and where both histograms store the frequency of grey level occurrence from malignant and normal regions, respectively. However, since many grey levels occur in both regions, we need to identify the distinctive grey levels which occur only in malignant or normal regions, and grey levels that occur both in malignant and normal regions. These allow us to differentiate malignant and normal grey tissues. These can be found by finding the intersection of and as shown in (5). In our case, intersection means a particular grey level can be found in both malignant and normal regions (i.e. grey level at the position 3990 th occurs in and , see Fig. 9 ) .
where is the histogram contains all the grey levels occur both in malignant and normal regions. Each grey level's frequency in is the mean of corresponding frequencies in and (e.g.
) with condition that the element is in and . By the end of this phase, we have three histogram models which present the only malignant ( ), only normal ( ) and malignant and normal ( ) grey levels. Fig. 7 and 8 show examples of malignant and normal grey level distributions from grey level 38,000 to 39,000, respectively. We chose only 1000 grey levels in the following examples so the differences are visible. Based on the examples in Fig. 7-9 we can clearly see that normal regions have higher occurrence within this range and very small occurrence for malignant grey levels within this range. However, it is possible that all grey levels in malignant regions only occur in (e.g. if all grey levels occur in we need further steps to determine abnormality). To reduce this problem we need to extract two more histograms from . Both histograms ( and ) represents the distribution of overlapping malignant and benign grey levels, respectively. In contrast to , and were constructed based on the exact number of occurrence of grey levels whereas is based on the average occurrence number of grey levels of and . Therefore, every grey level now has a weighted value and using these histogram models ( , , , and ) we could estimate the probability of abnormality using specific metrics.
B. Histogram Normalisation
Since the sum of outweighs considerably high the sum of and (caused false negative results), all models need to be normalised to ensure the weighting values for all grey levels are distributed evenly (used for the first metric only). By normalising all histogram models the sum for every histogram is equal to 1. The normalisation can be done using the following equation
where { } and (small ) indicates a normalised histogram. Therefore we get an equal summation of histogram but still different distributions and weighting value for every grey level's location.
C. Abnormality Detection
In the proposed method, abnormality detection is performed by calculating specific information from every histogram which is extracted from PZ. We use the following metrics to measure abnormality.
1) The sum of histogram multiplication ( ) for each with each of (e.g. and ). This can be calculated using the following equation ∑
This metric indicates the product of probability when every element in is multiplied with every element (frequency) in . This means, the higher the value of the more chance the slice has a tumor. For instance, means the malignant product of probability is higher when multiplied with compared to . A large number of indicates there are many grey levels in have the same grey level in (similar case in and ).
2
) The histogram intersection ( ) [22] between
and which can be calculated using the following
Based on (8), we do not use the normalised histograms ( ) but (denormalised histogram) instead, because normalised histograms could affect the value of histogram intersection due to the small values in which lead to incorrect results. We used this metrics as it has been successfully used for similarity measure in many different applications including medical image analysis. This metric measures the closeness of match between two histograms (in our case and ) . Higher value of indicates higher probability of the histograms is similar. In the proposed method, this matric is used to measure the closeness of a match between every with the histogram models. The closer the match with model the higher the value of . Finally, higher value means most gray levels in both histograms are distributed equally. Finally, now we have seven variables ( , , , , , and ) which will be used to determine as whether abnormality is present or not based on the decision rules in Fig. 10 . It should be noted that there are other metrics in the literature [23] available but these will be investigated in the future. Based on Fig.  10 , it is clearly shows that if , or value is higher than , or indicates higher probability of the prostate being abnormal. Similarly when the prostate's slice is more likely to be benign, the values of , or are greater than , or . In the next section we will present our experimental results.
IV. EXPERIMENTAL DATA
In this study, we used 243 slices of T2-Weighted MRI images taken 35 different patients aged 47 to 79. The data contains 88 slices of training data from 20 patients and 50% of the training data are malignant and the other half is normal. For evaluation purpose we used 155 slices of MRI images from 35 patients and 105 slices of them are malignant and 50 slices are normal. Our data were collected from Norfolk and Norwich Hospital University and for every slice all ground truths (prostate gland, central zone and tumor) were delineated by an expert radiologist.
V. EXPERIMENTAL RESULTS
This section presents the experimental results based on 155 slices T2-Weighted MRI images with 105 slices are malignant and 50 slices are normal from 35 different patients aged 49 to 74. The prostate, cancer and central zones were delineated by an expert radiologist on each of the images. Each slice was analysed and classified as to whether the prostate contains abnormality based on the methodology described in section three. Next, we compared the result with the ground truth as to whether the prostate contains cancer regions or not. An abnormality is considered to have been detected if the classification result is correct in comparison with the ground truth. We use several quantitative measures to evaluate the results such as sensitivity ( ), specificity ( ) and Accuracy ( ). Each of these metrics can be calculated using the following equations (9) (10) (11) where TP and FP denote the numbers of true positive and false positive, respectively. Similarly, TN and FN show the numbers of true negatives and false negatives. Accuracy means the number of correct classified slices out of the total number of slices. Sensitivity measures the proportion of actual positives which are correctly identified (in this case the percentage of malignant slice which are correctly identified) whereas specificity measures the proportion of actual negatives which are correctly identified (in this study the percentage of normal slice which are correctly identified).
The proposed method achieved 81% correct accuracy, which means 126 slices were classified correctly with 0.85 and 0.72 sensitivity and specificity, respectively. On the other hand, the proposed method produced 9% and 10% false positive and false negative results, respectively. In comparison with existing methods in the literature the proposed method achieved similar results. Nevertheless, it is extremely difficult to make a qualitative comparison due to the differences in datasets (different modalities such as T2-weighted (T2-W) MRI, diffusion-weighted (DWI) MRI, dynamic contrast enhanced (DCE) MRI, Magnetic resonance spectroscopy (MRS), etc.) and frameworks used by the other methods. However, to compare the proposed method, we cite several methods which have similar goals (detecting prostate cancer). There are many other methods in the literature but it is difficult to gather all of those methods (also space limitation) and we selected these methods (see Table 1 ) because they have at least one of the qualitative results (e.g. sensitivity) and it is clearly stated the number of cases used in the evaluation. Table 1 presents the experimental results of thirteen different methods including the proposed method and their accuracy, sensitivity, specificity and modalities. All methods were ordered based on accuracy, sensitivity and specificity accordingly. Note that some of the authors did not include one/two of these qualitative results (indicated as '-'). The method proposed in [9] and [24] achieved the highest correct classification rate (89%) followed by the method in [3] with 87% accuracy. Our method has similar accuracy result with the method in [26] with just 1% higher. In addition, the proposed method reported similar sensitivity with the methods proposed in [21] , [28] and [29] and the method of [24] reminds 89%. Although the method proposed in [27] achieved the highest sensitivity but the authors reported inconsistency of 81%-93%. The method in [18] achieved the lowest accuracy which is 57% whereas the method in [8] and [26] produced 76% and 67% sensitivity, respectively. On the other hand, the methods in [21] , [26] , [8] and [29] achieved high specificity 87%, 86%, 86% and 83%, respectively. The proposed method achieved only 72% but it is still higher than the methods proposed in [18] and [30] .
These comparisons are subjective because accuracy, sensitivity and specificity are highly influenced by the number of datasets, different modalities and methods' framework. For instance, although the method proposed in [26] and [29] achieved 86% and 83% specificity, respectively; the evaluation is based on smaller numbers of dataset (6 and 15 patients, respectively). On another study [31] shows higher sensitivity and specificity of 93% and 96%, respectively but based on 46 ultrasound images. Similarly, the method proposed in [24] and [9] achieved the highest accuracy but based on DCE and T2-W+DCE modalities, respectively. Therefore it is extremely difficult to make a direct comparison either quantitatively or qualitatively. However, for indirect comparison purpose our method achieved comparable results with the state of art. One obvious drawback of this method is since it entirely relying on the grey level distribution, the metrics could give inaccurate results if the data is heavily affected by noise (due to change of pixel intensity affected by noise).
VI. CONCLUSIONS
We have introduced a novel method for automated prostate cancer detection using grey level distribution. The proposed method achieved similar results to some of the methods in the literature. The proposed method shows that prostate abnormalities could be detected using grey level distribution by giving a weighted value (by normalising the histogram models) for each of the grey levels. Moreover, in this paper we have shown the importance of grey-level values in detecting prostate abnormality by assigning every grey level into different classes (e.g. malignant or benign) and assigning a weighting value for every single grey level's location. In short, with 9% and 10% false positive and false negative results, respectively we have achieved comparable results (81% accuracy out of 35 patients). Although it is difficult to make a quantitative comparison with the methods in Table 1 due the differences in datasets and frameworks, the main objective to show the potential of grey level distribution in detecting prostate cancer because it has been showed its potential in different human's body such as breast [15] , lung [13] and brain [14] . Finally, the next stage of this research is to test it on a larger dataset with several combination methods [20, 21] and applying a robust noise reduction method to improve its sensitivity and specificity.
